Skip to content
Recall Observatory FDA recall evidence

Drug product

TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufactured for IBSA Pharma Inc. by: IBSA Institut Biochimique SA, 6912 Pazzallo, Switzerland; Distributed by: IBSA Pharma Inc., Parsippany, NJ 07054; NDC 71858-0117-5

D-0339-2023

January 30, 2023

Class II

Product summary

Firm
IBSA PHARMA INC
Event
Event 91556
Status
Terminated
Classification
Class II
Quantity
N/A
Official record key
drug-enforcement:D-0339-2023

Official wording

Reason: Subpotent Drug

Code information: Lot #: 220556, Exp. 11/2023; 221058, Exp. 04/2024.

Distribution pattern: Nationwide in the USA.

Derived failure modes

  • Potency or specification failure

    reason.potency_specification_failure · v1.0.0

    Subpotent